Decrease in Urinary Tract Infections Following Switch From Anti-Interleukin-6 Monoclonal Antibody to Ravulizumab in a Patient With Neuromyelitis Optica Spectrum Disorder (NMOSD): A Case Report. [PDF]
Takahashi S +3 more
europepmc +1 more source
Long-term outcome and management of complement-mediated thrombotic microangiopathy/aHUS. [PDF]
Afshar-Kharghan V.
europepmc +1 more source
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment. [PDF]
Kulasekararaj A +9 more
europepmc +1 more source
Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Metastatic Pancreatic Cancer: A Case Report. [PDF]
Young J.
europepmc +1 more source
Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration. [PDF]
Bezirgiannidou Z +11 more
europepmc +1 more source
Hidden in the Kidney: Renal-Limited Thrombotic Microangiopathy Without Hemolysis. [PDF]
Keratishvili D +5 more
europepmc +1 more source
Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies. [PDF]
Apostolidou E +4 more
europepmc +1 more source
Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma. [PDF]
Takahata A, Tanaka K, Toyota S.
europepmc +1 more source
Thymoma Associated Myasthenia Gravis Successfully Treated With Ravulizumab
Vasiliki Zouvelou +7 more
openaire +3 more sources

